Literature DB >> 7143019

Methylprednisolone therapy in multiple sclerosis.

P K Newman, M Saunders, P J Tilley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7143019      PMCID： PMC491608          DOI： 10.1136/jnnp.45.10.941

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Methylprednisolone in multiple sclerosis: a comparative dose study.

Authors:  L Bindoff; P R Lyons; P K Newman; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

2.  Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.

Authors:  Ariella L G Coler-Reilly; Tomoo Sato; Toshio Matsuzaki; Masanori Nakagawa; Masaaki Niino; Masahiro Nagai; Tatsufumi Nakamura; Norihiro Takenouchi; Natsumi Araya; Naoko Yagishita; Eisuke Inoue; Yoshihisa Yamano
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Authors:  P R Lyons; P K Newman; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

4.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Authors:  N M Milligan; R Newcombe; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.